Immunopharmacology And Immunotoxicology

杂志介绍

Immunopharmacology And Immunotoxicology杂志介绍

《Immunopharmacology And Immunotoxicology》是一本以English为主的未开放获取国际优秀期刊，中文名称免疫药理学和免疫毒理学，本刊主要出版、报道医学-TOXICOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.9，最新CiteScore 指数为5.4。

本刊近期中国学者发表的论文主要有：

• Xanthones from securidaca inappendiculata antagonizes the anti-rheumatic effect of methotrexate by inhibiting reduced folate carrier 1

  Author: Zhang, Sa-sa; Wu, Yi-jin; Pan, Shu; Wang, Qi-hai; Chen, Wen-gang; Wang, Zhong-fang; Xu, Jin-ying; Zuo, Jian; Yin, Qin

• A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis

  Author: Liu, Tong; Jiang, Shuai; Teng, Xue; Zhong, Lu; Liu, Mengmeng; Jin, Yao; Dong, Mei

• Corynoline ameliorates dextran sulfate sodium-induced colitis in mice by modulating Nrf2/NF-kappa B pathway

  Author: Zhang, Haihua; Lang, Wuying; Li, Sufen; Xu, Chao; Wang, Xiumin; Li, Yunyu; Zhang, Zhiqiang; Wu, Tonglei; Feng, Minshan

• Sulforaphane suppresses skin squamous cell carcinoma cells proliferation through miR-199a-5p/Sirt1/CD44ICD signaling pathway

  Author: Zhang, Yang; Ai, Ping; Chen, Shang-zhou; Lei, Shu-ying

英文介绍

Immunopharmacology And Immunotoxicology杂志英文介绍

The journal Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system. Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs. Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal.

The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome.

With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more.

Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).